GENB

Name: Disclosed insider trades - GENB (US)
Creator: MoneyFlock
License: https://www.moneyflock.com/terms-and-conditions
Keywords: GENB insider trading, GENB sec form 4, GENB officer sales, GENB 10 percent owner, corporate insider trading, sec edgar form 4

Generate Biomedicines, Inc.

1 disclosed insider filing · 1 distinct insider · latest Sep 3, 2026

Total filings

1 insiders

Insider buys

Insider sells

$16K

Grants & other

All disclosed filings

Same-day tranches are grouped per insider - the Lots column shows how many individual executions a row covers; Price is the value-weighted average.

Filed	Tx date	Insider	Type	Qty	Avg price	Value	Lots	Source
Sep 3, 2026	Sep 1, 2026	Frances Arnold INSIDER	SELL	1,000	$16	$16K	—	EDGAR

Frances ArnoldSELL

INSIDER

1,000 sh @ $16 · $16K

Tx Sep 1, 2026EDGAR

About this data

This data is compiled from public disclosure data: Form 4 filings that US company insiders make with the SEC, published on EDGAR.

MoneyFlock does not collect information from the people listed. We publish only what appears in these public filings: names, roles, and reported trades or holdings (and, where a filing lists them, family members' holdings). We do not collect or display personal contact details such as email addresses, phone numbers or home addresses.

Figures are shown as filed and may contain errors from the original filings. This is not investment advice.

More about this data

Published free for the public's information and education.
MoneyFlock is not a broker or investment adviser and has no access to non-public information.
Do your own research before making any investment decision. MoneyFlock is not liable for decisions made using this data.
Insiders file after the trade (within 2 business days on SEC Form 4), so this data is always delayed.
MoneyFlock is not affiliated with the SEC.
Investments can lose value; past performance is not a guide to future results.

Corrections or privacy questions: contact@moneyflock.com. See how we handle public-record data.